Business

The Singapore stem cell banking scandal is causing concern for fogeys in Hong Kong, the Philippines and India

The company has “no respect and no remorse for losing something so worthwhile,” said one parent who was offered about A$5,000 (US$3,700). Any penalty imposed by Singapore’s Ministry of Health must function a warning to all cord blood banking providers, they said, asking to not be identified to guard the family’s privacy.

The agency found that roughly 2,200 units of cord blood in a single tank were defective and an estimated 5,300 units in one other tank and within the dry cargo shipment were “non-viable.” The cause was insufficient liquid nitrogen levels in tanks and inadequate monitoring by the dry goods carrier, which led to temperatures rising above acceptable levels several times since November 2020.

On April 17, Cordlife filed a police report accusing “mostly former” employees of potential wrongdoing over the defects. According to the filling company, earlier this 12 months its former CEO and five board members were arrested for allegedly violating disclosure obligations. The three remaining board members, including those that filed a police report, have had their interviews with authorities postponed.

Storage tanks using a liquid nitrogen gas phase storage system will be seen on the Cordlife facility in Hong Kong in 2012. Photo: Edmond So

The situation has raised eyebrows amongst the corporate’s customers elsewhere within the region, with parents in Hong Kong expressing their concerns about reservoirs of their area on social media.

Cordlife reviewed its operations in other markets and located no concerns, it said in an emailed response to questions.

Blood taken from the umbilical cord is stuffed with stem cells, a miraculous feat of biology that may turn into any sort of blood cell. They are particularly useful within the treatment of certain cancers, blood diseases corresponding to anemia, and a lot of immune system disorders. However, any genetic defects or other defects present on the time of the infant’s birth can even be detected within the stem cells, rendering them useless in some cases.

Some parents worry about losing potential protection.

It’s out of my control… Even if I call them day-after-day, I can not do anything

Madam Tan, a apprehensive parent in Singapore

Michelle Chan, certainly one of the parents, said she was attempting to get “appropriate compensation” so she could search for a future partner on her own. “I’m not concerned about the money I paid, but mainly about how to move forward,” she said.

Despite this, many medical organizations don’t support the usage of private cord blood banks.

Commercial organizations charge fees for collecting cord blood and an annual fee for storing it. The sample is reserved for the donor and family. Public banks accept umbilical cord blood donations freed from charge, but it surely is out there to anyone in need and shouldn’t be a reserve for the donating child.

Neither the American Academy of Pediatrics nor the American Medical Association recommends cord blood storage as a type of “biological insurance.” Most children never need it, and siblings only have a 25% likelihood of matching, making the advantages too rare to justify the prices. Alternative treatments are sometimes available, effective and less expensive, in keeping with their guidelines.

Cord blood is stuffed with stem cells that could be useful within the treatment of cancer, blood diseases and immune system disorders. The lack of potential protection for damaged samples has concerned some parents. Photo: Shutterstock

The study found that only one in 400 babies in 1 in 200,000 babies with stored cord blood will have the opportunity to make use of it for all times. Since the corporate was founded in 2001, only seven units have been recovered from Cordlife’s Singapore facility, and tens of 1000’s of families have used them to store blood samples.

Singapore’s Ministry of Health found similar blood utilization rates at other business cord blood banks in town.

The situation at Cordlife highlights the issue of policing the industry and the high costs of investigations when deficits are detected. The health ministry’s investigation began with a criticism filed by a citizen in July 2023, after the corporate underwent a routine inspection in late 2022. No other details can be found.

More testing is now needed for other tanks where temperature probes were incorrectly placed. They contain 14,000 units of umbilical cord blood, each of which is stored by a family wanting to guard the kid. Although the initial study of 30 samples passed the validity test, it will take one other 12 months and greater than 200 samples to acquire statistically significant results, in keeping with the Ministry of Health.

Single women in Singapore are ‘not being supported’ even after egg freezing rules are relaxed

The uncertainty weighs on parents who’ve paid prematurely to ease concerns about potential future medical risks.

Madam Tan, who gave just one name and has two sons with umbilical cord blood in tanks that also require testing, said she was unnerved by the situation.

“It’s out of my control,” she said. “Even if I call them every day, I can’t do anything.”

She paid greater than A$5,000 to store each son’s cord blood after seeing the corporate’s “one likelihood, one selection” ads at a personal clinic.

“It took advantage of young parents’ anxiety that there might be something perfectly tailored to help my child in case something happened,” she said.

Now he discovers that will not be the case.

admin
the authoradmin

Leave a Reply